Search Results - "Pauli, Franziska Di"

Refine Results
  1. 1

    Immunization status in patients with multiple sclerosis: A cross‐sectional, monocenter study in Austria by Berek, Klaus, Deisl, Philipp, Bichler, Maximilian, Auer, Michael, Barket, Robert, Bauer, Angelika, Zinganell, Anne, Di Pauli, Franziska, Deisenhammer, Florian, Hegen, Harald

    Published in European journal of neurology (01-05-2023)
    “…Background and purpose Patients with multiple sclerosis (MS) under certain disease‐modifying therapies (DMT) show a higher risk of infection and a lower immune…”
    Get full text
    Journal Article
  2. 2

    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study by Bsteh, Gabriel, Ehling, Rainer, Lutterotti, Andreas, Hegen, Harald, Di Pauli, Franziska, Auer, Michael, Deisenhammer, Florian, Reindl, Markus, Berger, Thomas

    Published in PloS one (08-07-2016)
    “…Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. The objective was to evaluate current and…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matter by Di Pauli, Franziska, Zinganell, Anne, Böttcher, Bettina, Walde, Janette, Auer, Michael, Barket, Robert, Berek, Klaus, Egger, Alexander, Griesmacher, Andrea, Sukalo, Natasa, Deisenhammer, Florian, Hegen, Harald

    Published in European journal of neurology (01-04-2023)
    “…Background and purpose Sexual dysfunction (SD) in people with multiple sclerosis (pwMS) is common and an often underestimated issue in the care of pwMS. The…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study by Hegen, Harald, Auer, Michael, Bsteh, Gabriel, Di Pauli, Franziska, Plavina, Tatiana, Walde, Janette, Deisenhammer, Florian, Berger, Thomas

    Published in PloS one (20-03-2017)
    “…Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. To investigate the…”
    Get full text
    Journal Article
  9. 9

    Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration by Bsteh, Gabriel, Berek, Klaus, Hegen, Harald, Teuchner, Barbara, Auer, Michael, Wurth, Sebastian, Di Pauli, Franziska, Deisenhammer, Florian, Berger, Thomas

    Published in Multiple sclerosis (01-01-2020)
    “…Background: Peripapillary retinal nerve fiber layer (pRNFL) thickness and olfactory function are both emerging biomarkers in multiple sclerosis (MS)…”
    Get full text
    Journal Article
  10. 10

    Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years by Auer, Michael, Zinganell, Anne, Hegen, Harald, Bsteh, Gabriel, Di Pauli, Franziska, Berek, Klaus, Fava, Elena, Wurth, Sebastian, Berger, Thomas, Deisenhammer, Florian

    Published in Scientific reports (02-12-2021)
    “…Natalizumab (NTZ) has been used for treatment of highly active relapsing–remitting multiple sclerosis (MS). When stopping NTZ the risk of severe rebound…”
    Get full text
    Journal Article
  11. 11

    Change of olfactory function as a marker of inflammatory activity and disability progression in MS by Bsteh, Gabriel, Hegen, Harald, Ladstätter, Felix, Berek, Klaus, Amprosi, Matthias, Wurth, Sebastian, Auer, Michael, Di Pauli, Franziska, Deisenhammer, Florian, Reindl, Markus, Berger, Thomas, Lutterotti, Andreas

    Published in Multiple sclerosis (01-02-2019)
    “…Background: Impaired olfactory threshold has been reported in early inflammatory phases of MS, while impaired odor identification was associated with more…”
    Get full text
    Journal Article
  12. 12

    Influence of physical activity on serum vitamin D levels in people with multiple sclerosis by Bauer, Angelika, Lechner, Ivan, Auer, Michael, Berger, Thomas, Bsteh, Gabriel, Di Pauli, Franziska, Hegen, Harald, Wurth, Sebastian, Zinganell, Anne, Deisenhammer, Florian, Ramagopalan, Sreeram V

    Published in PloS one (11-06-2020)
    “…In most cases, multiple sclerosis (MS) patients reduce physical activity with disease progression and many patients are found to be vitamin D deficient. The…”
    Get full text
    Journal Article
  13. 13

    Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases by Gredler, Viktoria, Mader, Simone, Schanda, Kathrin, Hegen, Harald, Di Pauli, Franziska, Kuenz, Bettina, Deisenhammer, Florian, Berger, Thomas, Reindl, Markus, Lutterotti, Andreas

    Published in Journal of the neurological sciences (15-05-2013)
    “…Abstract The aim of this observational study was to analyze clinical and immunological effects of rituximab treatment in neuromyelitis optica (NMO) and…”
    Get full text
    Journal Article
  14. 14

    Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? by Di Pauli, Franziska, Berger, Thomas

    Published in Frontiers in immunology (29-11-2018)
    “…Inflammatory demyelinating CNS syndromes include, besides their most common entity multiple sclerosis (MS), several different diseases of either monophasic or…”
    Get full text
    Journal Article
  15. 15

    Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis by Auer, Michael, Hegen, Harald, Hotter, Anna, Löscher, Wolfgang, Berek, Klaus, Zinganell, Anne, Fava, Elena, Rhomberg, Paul, Deisenhammer, Florian, Di Pauli, Franziska

    Published in Journal of central nervous system disease (09-03-2022)
    “…The chimeric anti-CD20 antibody rituximab has demonstrated good efficacy as an off-label treatment in chronic inflammatory demyelinating polyneuropathy (CIDP),…”
    Get full text
    Journal Article
  16. 16

    The spectrum of MOG autoantibody-associated demyelinating diseases by Reindl, Markus, Di Pauli, Franziska, Rostásy, Kevin, Berger, Thomas

    Published in Nature reviews. Neurology (01-08-2013)
    “…In this Review, Reindl et al . discuss a range of CNS disorders that are known to be associated with autoantibodies against myelin oligodendrocyte glycoprotein…”
    Get full text
    Journal Article
  17. 17

    Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria by Bsteh, Gabriel, Algrang, Laura, Hegen, Harald, Auer, Michael, Wurth, Sebastian, Di Pauli, Franziska, Deisenhammer, Florian, Berger, Thomas

    Published in Multiple sclerosis (01-01-2020)
    “…Background: Multiple sclerosis (MS) predominantly affects women of child-bearing potential. Pregnancy in MS is still a controversial issue lacking standardized…”
    Get full text
    Journal Article
  18. 18

    Multiple sclerosis and COVID‐19: How many are at risk? by Bsteh, Gabriel, Bitschnau, Christina, Hegen, Harald, Auer, Michael, Di Pauli, Franziska, Rommer, Paulus, Deisenhammer, Florian, Berger, Thomas

    Published in European journal of neurology (01-10-2021)
    “…Background and Purpose The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis by Bsteh, Gabriel, Berek, Klaus, Hegen, Harald, Altmann, Patrick, Wurth, Sebastian, Auer, Michael, Zinganell, Anne, Di Pauli, Franziska, Rommer, Paulus, Leutmezer, Fritz, Deisenhammer, Florian, Berger, Thomas

    Published in Multiple sclerosis (01-04-2021)
    “…Background: Macular ganglion cell–inner plexiform layer (mGCIPL) is an emerging biomarker of neuroaxonal degeneration in multiple sclerosis (MS). Objective: We…”
    Get full text
    Journal Article